This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
DNASTAR announced today the release of Lasergene 17.3, which includes new features and functionality focused on genomic analysis and variant identification supporting COVID-19 research.
Genetic analyses uncover cellular hallmarks of bladder cancer tumors that don’t respond, but interfering with one of those characteristics in a mouse model causes tumors to shrink.